January 23, 2019 / 3:12 PM / 9 months ago

Abbott Labs says M&A not a high priority now

(Reuters) - Healthcare company Abbott Laboratories (ABT.N) will not focus on mergers and acquisitions in the near future, Chief Executive Officer Miles White said on a conference call on Wednesday.

“I just don’t see M&A right now as a high priority,” White said.

“You make a much higher return on your organic growth,” White said, adding that he did not see gaps right now that could be filled by M&A.

Reporting by Manas Mishra in Bengaluru; Editing by Shounak Dasgupta

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below